ECO Animal Health Group’s (EAH) Buy Rating Reiterated at Shore Capital

Shore Capital reissued their buy rating on shares of ECO Animal Health Group (LON:EAH) in a report issued on Friday, Marketbeat Ratings reports.

ECO Animal Health Group Trading Down 0.3 %

Shares of EAH opened at GBX 71.25 ($0.90) on Friday. ECO Animal Health Group has a 1-year low of GBX 60 ($0.76) and a 1-year high of GBX 135 ($1.71). The firm has a market capitalization of £48.26 million, a price-to-earnings ratio of 3,740.00 and a beta of -0.05. The firm’s 50-day moving average price is GBX 74.68 and its 200-day moving average price is GBX 101.87. The company has a current ratio of 2.96, a quick ratio of 2.14 and a debt-to-equity ratio of 4.31.

About ECO Animal Health Group

ECO Animal Health Group plc, together with its subsidiaries, develops, registers, and markets pharmaceutical products for animals worldwide. The company provides Aivlosin, a macrolide antibiotic for the treatment of enteric and respiratory diseases in pigs and poultry. It also offers generic drugs, such as Ecomectin, Ecoheart, Ecotraz, and Ecomintic, which are endectocides and other antiparasitics for the treatment and prevention of parasites, such as worms, ticks, mange, and lices in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infections in pigs, poultry, and cattle.